Primary renal lymphoma (PRL) is a rare disease which is often mistaken for renal cell carcinoma. In the present study, a 56-year-old man visited a clinic complaining of an intermittent fever and right flank pain. A computerized tomography examination revealed a hypoenhancing mass in his right kidney. Radical nephrectomy was conducted, and a diagnosis of diffuse large B-cell lymphoma was confirmed. The present case was determined to be a true PRL according to the results of a positron emission tomography examination and a bone marrow biopsy to rule out any lymphoma invasions apart from the right kidney.
Introduction
Malignant lymphoma, especially non-Hodgkin lymphoma (NHL), may arise in tissues with no infiltration of the lymph nodes, spleen, Waldeyer's ring, or thymus; such cases are referred to as primary extranodal NHL. This form accounts for one-third of all NHL cases (1) . Diffuse large B-cell lymphoma (DLBCL) is the predominant type of NHL, accounting for approximately 40% of all lymphomas (2, 3) . It has also been reported that 30-50% of NHL cases have extranodal manifestations in various organs, such as the gastric tract, skin, bone, central nervous system, breast, heart, liver, or adrenal glands (1) .
Although renal involvement is a common finding in the patients with advanced stages of NHL, ranging from 37 to 47% (4), primary renal lymphoma (PRL) is quite rare and it is often mistaken for renal cell carcinoma (RCC). PRL is thought to originate in the lymph nodes of the renal sinus or in the lymphatic network of the renal capsule (5) and to manifest as focal masses (solitary or multiple), large infiltrative lesions engulfing the kidney, or diffuse bilateral enlarged kidneys (6) . Most patients additionally have adjacent retroperitoneal adenopathy. Currently, more than 50 cases have been reported in the literature; however, a large proportion of these patients did not undergo standard procedures or a recently developed [18F] fluorodeoxyglucose (FDG) positron emission tomography (PET) scan (FDG-PET) to rule out infiltration in other extra-organs or lymph nodes. In the present case, after radical nephrectomy, a very strict staging that included a FDG-PET examination was conducted. The results indicated that no other infiltrations, including contiguous lymph nodes and the opposite kidney, were found. Thus, the patient was considered to be a rare case of true PRL.
Case Report
A 56-year-old Japanese man visited his family doctor due to an intermittent fever and right flank pain. He was initially referred to a hospital in his community. A computerized tomography (CT) examination revealed a medium sized mass (6.6×5 cm in diameter) in the posterior right kidney. Thereafter, he was transferred to our hospital to undergo surgery. After this admission, a contrast-enhanced CT examination showed a hypoenhanced renal tumor, which was diagnosed to be a papillary or chromophobe RCC or sarcoma by the radiologist (Fig. 1) . The laboratory findings were as follows: leukocyte count, 4,700/μL; hemoglobin, 14.6 g/dL; platelet count, 44×10 4 /μL; serum creatinine, 0.9 mg/dL; aspartate aminotransferase, 14 IU/L; alanine aminotransferase, 22 IU/ L; lactate dehydrogenase, 118 IU/L; C-reactive protein, 0.22 mg/dL; and soluble interleukin-2 receptor, 300 U/mL. There was no abnormal finding in the urine sample. The patient underwent radical nephrectomy and resection of the marginal lymph nodes. A histological examination provided a diagnosis of DLBCL ( Fig. 2) , which was only observed in the kidney. The CT scans of the cervical and chest regions and a bone marrow biopsy did not indicate any findings of lymphoma invasion. A FDG-PET analysis after surgery showed a weak FDG uptake (SUVmax 3-4) around the resected kidney, which was potentially caused by postoperational inflammation (Fig. 3) . According to these results, the patient was diagnosed with PRL. The patient was then treated with 6 cycles of combination chemotherapy consisting of rituximab and cyclophosphamide, hydroxydaunomycin, oncovin and prednisolone (CHOP) at the standard dose. He is currently alive in complete remission at 14 months after the disease onset.
Discussion
Renal involvement in NHL is not uncommon during the disseminated phase of the disorder, with a reported incidence of as high as 47% among the autopsy cases (4). In contrast, PRL is quite rare. In 2000, Stallone et al. reviewed the available literature and reported only 29 cases of PRL fulfilling three diagnostic criteria: 1) lymphomatous renal in- filtration 2) non-obstructive uni-or bilateral kidney enlargement, and 3) no extrarenal localization at the time of diagnosis (7). PRL comprises 0.7% of the extra nodal lymphomas (8) and 0.1% of all malignant lymphomas (9) . Furthermore, Chen et al. reviewed a large number (5,490) of renal neoplasms tha had been diagnosed using the resected or biopsy specimens over a 27-year period at their institution and found that PRL accounted for only 29 (0.5%) of all the cases with lymphoproliferative disorders. Prior to the pathological examination, almost half (14 out of 29) of these cases were presumptively diagnosed to be renal carcinomas, similar to the present case. According to the staging procedures, 26 of the 29 cases had documented nodal and/or other extranodal involvement and ultimately none of the patients met the above-mentioned criteria (10) . Since 1990, a total of 37 cases have been published to be due to PRL (shown in Table) (4, . Thirty-two cases occurred in patients over 50 years of age, the male to female ratio was 24:13 (in one case, the patient's sex was not mentioned), and unilateral and bilateral involvement occurred in 28 and 8 cases, respectively (not mentioned in one case). DLBCL was the most common histological type (19 cases) and extranodal marginal zone B-cell lymphoma of mucosaassociated lymphoid tissue (MALT lymphoma) was the second most common (13 cases). The predominant initial symptoms were pain and/or a fever. Renal lymphoma is typically a hypovascular tumor in contrast to the much more common hypervascular, clear cell type of RCC (6) . Even if the incidence is quite low, the papillary or chromophobe subtypes of RCC or renal sarcoma present as a hypovascular mass. Ye et al. recently reported that the FDG uptake by lymphoma lesions was much higher than that by renal carcinomas, suggesting that PET/ CT could be useful for the diagnosis of renal lymphoma (35) . A similar pattern for PET/CT imaging has also been reported for the papillary and chromophobe subtypes of RCC (36) . Therefore, in addition to the traditional ultrasound, CT or magnetic resonance imaging (37), the use of PET/CT could help radiologists to suggest or raise the possibility of lymphoma as a possible diagnosis. Earlier reports have shown that cases other than the indolent type of marginal zone lymphoma have a poor prognosis with a median survival of less than one year (4). Such cases behave in an aggressive manner and often disseminate to the lymph nodes (21) or other organs including the central nervous system (11, 20, 26) Until now, a limited number of cases has been published in which the lymphoma cells were proven to have been restricted to the kidney based on the PET analysis (11, 25, 31) . If PET/CT had been used as a routine investigation, previously diagnosed PRL cases may have been revised to disseminated or advanced stages of lymphomas and the prognosis of the limited stage should be equivocal to those of other common types of DLBCL. Indeed, an initial description of an excellent outcome after the addition of rituximab to the CHOP regimen has led to many recent cases being successfully cured using chemotherapy alone (refs. 17, 18, 21, 27, 31, 33, 34 in Table) .
Hunter et al. emphasized the usefulness of an imageguided percutaneous biopsy, which detected the lymphoma samples in 11 out of 407 samples (3%) at their institution. The sensitivity and specificity of such renal biopsies are relatively high, reaching 70 to 92% and 100%, respectively (12) . In contrast to previous reports (38) , more cases have been diagnosed using this approach without a radical nephrectomy. In the near future diagnostic nephrectomy may be avoidable according to the results of a renal biopsy combined with those from a PET/CT examination.
The authors state that they have no Conflict of Interest (COI).

